Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination. Boutros, C.; Tarhini, A.; Routier, E.; Lambotte, O.; Ladurie, F. L.; Carbonnel, F.; Izzeddine, H.; Marabelle, A.; Champiat, S.; Berdelou, A.; Lanoy, E.; Texier, M.; Libenciuc, C.; Eggermont, A. M.; Soria, J. C.; Mateus, C.; Robert, C.. Nat Rev Clin Oncol. 2016; 473-86: p.473-86. doi:10.1038/nrclinonc.2016.58 10.1038/nrclinonc.2016.58. Epub 2016 May 4.Article
Oncostat